XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Changes in Contingently Redeemable Convertible Preferred Stock and Stockholders’ (Deficit) Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Contingently Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021   10,826        
Beginning balance at Dec. 31, 2021   $ 44,476        
Increase (Decrease) in Temporary Equity [Roll Forward]            
Conversion of contingently redeemable preferred stock to common stock (in shares)   (10,826)        
Conversion of contingently redeemable preferred stock to common stock   $ (44,476)        
Ending balances (in shares) at Jun. 30, 2022   0        
Ending balance at Jun. 30, 2022   $ 0        
Beginning balance (in shares) at Dec. 31, 2021     271,576      
Beginning balance at Dec. 31, 2021 $ 1,341,210   $ 27 $ 1,379,581 $ (27,432) $ (10,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (1,276,679)       (1,276,679)  
Other comprehensive income, net of $— income taxes 35,746         35,746
Stock-based compensation 136,065     136,065    
Exercise of stock options (in shares)     1,321      
Exercise of stock options 3,846     3,846    
Restricted stock awards issued, net of shares withheld for tax withholding obligations (in shares)     34,202      
Restricted stock awards issued, net of shares withheld for tax withholding obligations (29,277)   $ 4 (29,281)    
Exercise of convertible notes (in shares)     197      
Exercise of convertible notes 1,574     1,574    
Cashless exercise of warrants (in shares)     3,001      
Cashless exercise of warrants 0          
Conversion of contingently redeemable preferred stock to common stock (in shares)     10,826      
Conversion of contingently redeemable preferred stock to common stock 44,476   $ 1 44,475    
Issuances of common stock - Merger with XPDI (in shares)     30,778      
Issuances of common stock - Merger with XPDI 163,459   $ 3 163,456    
Issuances of common stock - vendor settlement (in shares)     1,580      
Issuances of common stock - vendor settlement 12,674     12,674    
Costs attributable to issuance of common stock and equity instruments - Merger with XPDI (16,642)     (16,642)    
Ending balance (in shares) at Jun. 30, 2022     353,481      
Ending balance at Jun. 30, 2022 416,452   $ 35 1,695,748 (1,304,111) 24,780
Beginning balance (in shares) at Mar. 31, 2022   0        
Beginning balance at Mar. 31, 2022   $ 0        
Ending balances (in shares) at Jun. 30, 2022   0        
Ending balance at Jun. 30, 2022   $ 0        
Beginning balance (in shares) at Mar. 31, 2022     324,564      
Beginning balance at Mar. 31, 2022 1,126,710   $ 32 1,604,116 (493,636) 16,198
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (810,475)       (810,475)  
Other comprehensive income, net of $— income taxes 8,582         8,582
Stock-based compensation 115,492     115,492    
Exercise of stock options (in shares)     1,321      
Exercise of stock options 3,846     3,846    
Restricted stock awards issued, net of shares withheld for tax withholding obligations (in shares)     27,399      
Restricted stock awards issued, net of shares withheld for tax withholding obligations (29,277)   $ 3 (29,280)    
Exercise of convertible notes (in shares)     197      
Exercise of convertible notes 1,574     1,574    
Ending balance (in shares) at Jun. 30, 2022     353,481      
Ending balance at Jun. 30, 2022 $ 416,452   $ 35 1,695,748 (1,304,111) $ 24,780
Beginning balance (in shares) at Dec. 31, 2022 375,225   375,225      
Beginning balance at Dec. 31, 2022 $ (409,346)   $ 36 1,764,368 (2,173,750)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (388)       (388)  
Ending balance (in shares) at Mar. 31, 2023     377,841      
Ending balance at Mar. 31, 2023 $ (397,461)   $ 36 1,776,641 (2,174,138)  
Beginning balance (in shares) at Dec. 31, 2022 375,225   375,225      
Beginning balance at Dec. 31, 2022 $ (409,346)   $ 36 1,764,368 (2,173,750)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (9,648)       (9,648)  
Other comprehensive income, net of $— income taxes 0          
Stock-based compensation 26,553     26,553    
Restricted stock awards issued, net of shares withheld for tax withholding obligations (in shares)     3,866      
Restricted stock awards issued, net of shares withheld for tax withholding obligations $ 0   $ 0 0    
Ending balance (in shares) at Jun. 30, 2023 379,091   379,091      
Ending balance at Jun. 30, 2023 $ (392,441)   $ 36 1,790,921 (2,183,398)  
Beginning balance (in shares) at Mar. 31, 2023     377,841      
Beginning balance at Mar. 31, 2023 (397,461)   $ 36 1,776,641 (2,174,138)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (9,260)       (9,260)  
Other comprehensive income, net of $— income taxes 0          
Stock-based compensation 14,280     14,280    
Restricted stock awards issued, net of shares withheld for tax withholding obligations (in shares)     1,250      
Restricted stock awards issued, net of shares withheld for tax withholding obligations $ 0   $ 0 0    
Ending balance (in shares) at Jun. 30, 2023 379,091   379,091      
Ending balance at Jun. 30, 2023 $ (392,441)   $ 36 $ 1,790,921 $ (2,183,398)